Skip to main content
. 2023 Oct 5;14:1266679. doi: 10.3389/fendo.2023.1266679

Table 4.

Univariate and multivariate logistic analysis for identifying surgical benefit-related variables in BC patients with BM.

Variables Univariate analysis Multivariate analysis
OR 95%CI p-value OR 95%CI p-value
Age
 < 60 years Reference
 ≥ 60 years 0.757 0.584-0.981 0.036
Race
 African American Reference Reference
 Other 1.548 0.857-2.796 0.148 1.412 0.765-2.605 0.270
 Caucasian populations 2.128 1.482-3.057 <0.001 2.017 1.377-2.954 <0.001
Sex
 Female Reference
 Male 3.702 0.743-18.441 0.110
Laterality
 Left Reference
 Right 0.857 0.661-1.111 0.245
Grade
 I Reference
 II 0.795 0.499-1.268 0.336
 III 0.469 0.295-0.748 0.001
 IV 0.002 0.001-0.003 1.000
T stage
 T1-2 Reference Reference
 T3-4 0.674 0.519-0.875 0.003 0.736 0.559-0.970 0.029
N stage
 N0 Reference
 N1-3 0.778 0.564-1.074 0.127
Primary site
 Central portion of breast Reference
 Lower-inner 1.053 0.453-2.444 0.905
 Lower-outer 1.228 0.568-2.653 0.601
 Upper-inner 0.992 0.518-1.902 0.982
 Upper-outer 0.847 0.510-1.406 0.520
 Other 0.795 0.491-1.286 0.349
Histology
 Ductal Reference
 Lobular 0.995 0.661-1.497 0.980
Other 0.752 0.505-1.121 0.162
Breast subtype
 HR+/HER2- Reference Reference
 HR+/HER2+ 1.301 0.898-1.885 0.164 1.571 1.065-2.318 0.023
 HR-/HER2+ 0.657 0.378-1.142 0.137 0.948 0.531-1.694 0.858
 HR-/HER2- 0.184 0.102-0.331 <0.001 0.234 0.128-0.427 <0.001
Tumor size
 < 5 cm Reference
 5-10 cm 0.722 0.546-0.955 0.022
 > 10 cm 0.437 0.249-0.766 0.004
Lung metastasis
 No Reference
 Yes 0.703 0.506-0.978 0.036
Liver metastasis
 No Reference Reference
 Yes 0.483 0.336-0.696 <0.001 0.510 0.346-0.752 0.001
Brain metastasis
 No Reference Reference
 Yes 0.457 0.218-0958 0.038 0.400 0.179-0.894 0.026
Surgery to DM
 No Reference
 Yes 1.447 0.761-2.754 0.260
Radiotherapy
 No Reference Reference
 Yes 1.373 1.052-1.792 0.020 1.527 1.147-2.032 0.004
Chemotherapy
 No Reference
 Yes 0.994 0.765-1.291 0.961